🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07574398
Recruiting Observational

A Survey on Growth Development in Children After Liver Transplantation

NCT07574398 · tracked via the Priya Life Science China tracker
Sponsor
RenJi Hospital
Phase
Observational
Started
2024-11-20
Last updated
2026-05-07

Condition(s) studied

Growth, Development in Pediatric Liver Transplant Recipients

Study summary

A single-center, large-sample, long-term longitudinal study was conducted to explore the trends and characteristics of changes in growth, development in pediatric liver transplant recipients, with the aim of guiding the development of intervention strategies and optimizing follow-up protocols.

Eligibility

Sex
ALL
Min age
—
Max age
1 Year
Healthy volunteers
No
Inclusion Criteria: * Children with end-stage liver disease of various etiologies requiring liver transplantation. * Approved by the ethics committee, and written informed consent has been obtained from the parents/legal guardians. * Age ≤ 1 year (infancy). Exclusion Criteria: * Age older than 1 year old. * Accept liver kidney combined transplantation surgery or second liver transplantation surgery.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine Shanghai Shanghai Municipality Recruiting

More RenJi Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07574398 on ClinicalTrials.gov ↗ ← All trials in China